Skip to main content
. 2011 Feb 20;13(4):393–400. doi: 10.1093/neuonc/noq204

Table 1.

Patient characteristics and survival durations

Steroidsa
Patient Age, years Sex PRE POST Survival duration, months
1 61 M Y N 12
2 67 F N N 19
3 73 F N N 11
4 52 M Y N 61+
5 71 M N N 24
6 73 M N N 19
7 69 M Y N 17
8 66 F Y N 31
9 66 F Y N 17
10 69 F Y N 9
11 59 F Y N 52+
12 66 M Y N 20
13 78 M N N 26
14 54 F Y N 15
15 60 F Y N 17
16 57 M Y N 30
17 47 M N N 35+
18 59 M Y N 34+
19 55 M Y Y 20
20 55 M Y N 15
21 64 M Y N 12
22 23 M Y N 33
23 75 M N N 14
24 59 M Y N 18
25 65 M Y N 12
Median 64 19
Range 23–78 11–60+

F indicates female, and M indicates male. Y indicates yes, and N indicates no. + indicates that the patient is alive.

aPatient receiving steroids at the PRE and POST time points.